Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Arcus Biosciences, Inc. (RCUS) had Debt to Capital Ratio of 0.14 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$247.00M |
|
$-353.00M |
|
-- |
|
$247.00M |
|
$633.00M |
|
$-386.00M |
|
$33.00M |
|
$-353.00M |
|
$-353.00M |
|
$-353.00M |
|
$-353.00M |
|
$-353.00M |
|
$-353.00M |
|
$-386.00M |
|
$-389.00M |
|
107.40M |
|
107.40M |
|
$-3.29 |
|
$-3.29 |
|
| Balance Sheet Financials | |
$1.01B |
|
$40.00M |
|
$132.00M |
|
$1.14B |
|
$231.00M |
|
$99.00M |
|
$277.00M |
|
$508.00M |
|
$631.00M |
|
$631.00M |
|
$631.00M |
|
125.30M |
|
| Cash Flow Statement Financials | |
$-482.00M |
|
$66.00M |
|
$488.00M |
|
$153.00M |
|
$225.00M |
|
$72.00M |
|
$60.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.36 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.14 |
0.16 |
|
100.00% |
|
-156.28% |
|
-156.28% |
|
-157.49% |
|
-142.91% |
|
-142.91% |
|
$-484.00M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
22.45 |
|
16.26 |
|
-55.94% |
|
-55.94% |
|
-30.99% |
|
-48.36% |
|
$5.04 |
|
$-4.51 |
|
$-4.49 |
|